JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB50332

Anti-PADI4 / PAD4 antibody

Be the first to review this product! 리뷰 제출

|

(13 제품이 사용된 논문 )

Rabbit Polyclonal PADI4 / PAD4 antibody. Suitable for WB and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Synthetic Peptide within Human PADI4 aa 1-50.
2 이미지
Western blot - Anti-PADI4 / PAD4 antibody (AB50332)
  • WB

Unknown

Western blot - Anti-PADI4 / PAD4 antibody (AB50332)

All lanes:

Western blot - Anti-PADI4 / PAD4 antibody (ab50332) at 1/1000 dilution

Lane 1:

293-T cells

Lane 2:

293-T cells transfected with PADI4 cDNA

Lane 3:

HL60 cells

Lane 4:

HL60 cells induced with 1.25% DMSO for three days

Secondary

All lanes:

Goat Anti-Rabbit IgG

Predicted band size: 74 kDa

Observed band size: ~62 kDa

false

Western blot - Anti-PADI4 / PAD4 antibody (AB50332)
  • WB

CiteAb

Western blot - Anti-PADI4 / PAD4 antibody (AB50332)

PADI4 / PAD4 western blot using anti-PADI4 / PAD4 antibody ab50332. Publication image and figure legend from Sharma, P., Azebi, S., et al., 2012, PLoS Genet, PubMed 23028349.

ab50332 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab50332 please see the product overview.

An antibody specific for histone H3cit8K9me3 reveals increased levels of this double modification catalyzed by PADI4.(A) Epitope used to generate the anti-H3cit8K9me3 antibody. The antibody was raised against a peptide mimicking histone H3 citrullinated at position 8 and tri-methylated on K9. (B) Dot blot highlighting the specificity of the anti-H3cit8K9me3, performed with 1, 0.2, and 0.04 µg of H3 peptides bearing the indicated post-translational modifications. (C) Specificity of the anti-H3cit8K9me3 antibody test by competition with H3 peptides. MCF7 cells were extracted, fixed and incubated with the indicated peptides along with anti-H3cit8K9me3 antibodies and DAPI. Scale bar 5 µm. (D) Similar staining with anti-H3cit8K9me3 and anti-H3cit(2,8,17) antibodies. Indirect immunofluorescent staining of MCF7 cells with DAPI to visualize the DNA and either anti-H3cit8K9me3 (b1–b2) or anti-H3cit(2,8,17) (b3–b4). (E) HEK293 cells that stably integrate a ponasterone A-inducible construct with either no insert (NI) or an insert coding for wild-type (WT), hyperactive (Mut+), or hypoactive (Mut−) PADI4 were cultured without or with ionophore (A23187). Total protein extracts were immunoblotted with the indicated antibodies. Signals were quantified with the Image J software (NI without treatment set to 1).

false

주요 정보

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human PADI4 aa 1-50. The exact immunogen used to generate this antibody is proprietary information.

Q9UM07

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/2000", "WB-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Ion exchange chromatography
보관 버퍼
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

PADI4 also known as PAD4 PADI4 protein or PAD-4 is an enzyme that plays a mechanical role in post-translational modification. It functions by catalyzing the conversion of arginine residues into citrulline in histones a process known as citrullination or deimination. This enzyme exhibits a molecular mass of approximately 74 kDa and is expressed notably in tissues like bone marrow and sites of inflammation. PADI4 shows high expression in immune cells such as neutrophils which are important for inflammatory responses.
Biological function summary

The PADI4 protein impacts gene expression by modifying chromatin architecture making it part of chromatin remodeling activities. PADI4 is known to associate with chromatin but it does not form large stable complexes. It influences the transcriptional activity of genes by altering histone interactions which can affect immune responses and cellular differentiation. Through these chromatin changes PADI4 plays a notable role in regulating genes associated with immune function and inflammatory responses.

Pathways

PADI4 integrates into the inflammatory response and apoptosis pathways. It influences apoptosis by modulating pro-inflammatory gene expression and participating in the formation of neutrophil extracellular traps (NETs). PADI4 works with other proteins such as histone H3 and histone H4 to influence immune cell pathways. These interactions underline its role in the regulation of protein expressions during inflammation and immune-mediated processes.

PADI4 connects to rheumatoid arthritis (RA) and certain cancers. In rheumatoid arthritis altered activity of PADI4 can lead to the production of autoantibodies against citrullinated proteins which exacerbates inflammation in joints. The enzyme’s dysregulation is also implicated in cancer progression where it may affect tumor growth and metastasis. PADI4’s interaction with other proteins like citrullinated histones highlights its association with pathogenic processes in such diseases.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Catalyzes the citrullination/deimination of arginine residues of proteins such as histones, thereby playing a key role in histone code and regulation of stem cell maintenance (PubMed : 15339660, PubMed : 15345777, PubMed : 16567635, PubMed : 21245532). Citrullinates histone H1 at 'Arg-54' (to form H1R54ci), histone H3 at 'Arg-2', 'Arg-8', 'Arg-17' and/or 'Arg-26' (to form H3R2ci, H3R8ci, H3R17ci, H3R26ci, respectively) and histone H4 at 'Arg-3' (to form H4R3ci) (PubMed : 15339660, PubMed : 15345777, PubMed : 16567635, PubMed : 21245532). Acts as a key regulator of stem cell maintenance by mediating citrullination of histone H1 : citrullination of 'Arg-54' of histone H1 (H1R54ci) results in H1 displacement from chromatin and global chromatin decondensation, thereby promoting pluripotency and stem cell maintenance (PubMed : 15339660, PubMed : 15345777, PubMed : 16567635, PubMed : 21245532). Promotes profound chromatin decondensation during the innate immune response to infection in neutrophils by mediating formation of H1R54ci (PubMed : 18209087). Required for the formation of neutrophil extracellular traps (NETs); NETs are mainly composed of DNA fibers and are released by neutrophils to bind pathogens during inflammation (By similarity). Citrullination of histone H3 prevents their methylation by CARM1 and HRMT1L2/PRMT1 and represses transcription (PubMed : 15345777). Citrullinates EP300/P300 at 'Arg-2142', which favors its interaction with NCOA2/GRIP1 (PubMed : 15731352).
See full target information PADI4

대체 명칭 보기

PAD4, PADI5, PDI5, PADI4, Protein-arginine deiminase type-4, HL-60 PAD, Peptidylarginine deiminase IV, Protein-arginine deiminase type IV

제품이 사용된 논문 (13)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Nature communications 15:9746 PubMed39528459

2024

A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation.

Applications

Unspecified application

Species

Unspecified reactive species

M Teresa Bertran,Robert Walmsley,Thomas Cummings,Iker Valle Aramburu,Donald J Benton,Rocio Mora Molina,Jayalini Assalaarachchi,Maria Chasampalioti,Tessa Swanton,Dhira Joshi,Stefania Federico,Hanneke Okkenhaug,Lu Yu,David Oxley,Simon Walker,Venizelos Papayannopoulos,Hiroaki Suga,Maria A Christophorou,Louise J Walport

International journal of molecular sciences 25: PubMed39201443

2024

Sodium Acetate Enhances Neutrophil Extracellular Trap Formation via Histone Acetylation Pathway in Neutrophil-like HL-60 Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hiroyuki Yasuda,Yutaka Takishita,Akihiro Morita,Tomonari Tsutsumi,Naoya Nakagawa,Eisuke F Sato

Biology 10: PubMed33805829

2021

Post-Translational Protein Deimination Signatures in Plasma and Plasma EVs of Reindeer ().

Applications

Unspecified application

Species

Unspecified reactive species

Stefania D'Alessio,Stefanía Thorgeirsdóttir,Igor Kraev,Karl Skírnisson,Sigrun Lange

International journal of molecular sciences 22: PubMed33573274

2021

Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.

Applications

Unspecified application

Species

Unspecified reactive species

Pinar Uysal-Onganer,Stefania D'Alessio,Maria Mortoglou,Igor Kraev,Sigrun Lange

Nature communications 12:45 PubMed33398026

2021

Site-specific incorporation of citrulline into proteins in mammalian cells.

Applications

Unspecified application

Species

Unspecified reactive species

Santanu Mondal,Shu Wang,Yunan Zheng,Sudeshna Sen,Abhishek Chatterjee,Paul R Thompson

International journal of molecular sciences 21: PubMed32326590

2020

Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Marco Sancandi,Pinar Uysal-Onganer,Igor Kraev,Audrey Mercer,Sigrun Lange

International journal of molecular sciences 21: PubMed32098295

2020

Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.

Applications

Unspecified application

Species

Unspecified reactive species

Pinar Uysal-Onganer,Amy MacLatchy,Rayan Mahmoud,Igor Kraev,Paul R Thompson,Jameel M Inal,Sigrun Lange

The Journal of organic chemistry 85:1691-1697 PubMed31875401

2020

Synthesis of an Alkynyl Methylglyoxal Probe to Investigate Nonenzymatic Histone Glycation.

Applications

Unspecified application

Species

Unspecified reactive species

Qingfei Zheng,Igor Maksimovic,Akhil Upad,David Guber,Yael David

International journal of molecular sciences 20: PubMed30597867

2018

Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.

Applications

Unspecified application

Species

Unspecified reactive species

Uchini S Kosgodage,Pinar Uysal-Onganer,Amy MacLatchy,Igor Kraev,Nicholas P Chatterton,Anthony P Nicholas,Jameel M Inal,Sigrun Lange

Nature chemical biology 11:189-91 PubMed25622091

2015

Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Applications

Unspecified application

Species

Unspecified reactive species

Huw D Lewis,John Liddle,Jim E Coote,Stephen J Atkinson,Michael D Barker,Benjamin D Bax,Kevin L Bicker,Ryan P Bingham,Matthew Campbell,Yu Hua Chen,Chun-Wa Chung,Peter D Craggs,Rob P Davis,Dirk Eberhard,Gerard Joberty,Kenneth E Lind,Kelly Locke,Claire Maller,Kimberly Martinod,Chris Patten,Oxana Polyakova,Cecil E Rise,Martin Rüdiger,Robert J Sheppard,Daniel J Slade,Pamela Thomas,Jim Thorpe,Gang Yao,Gerard Drewes,Denisa D Wagner,Paul R Thompson,Rab K Prinjha,David M Wilson
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com